november AG

euro adhoc: november AG
Mergers - Acquisitions - Takeovers
november AG assigns peqlab

-------------------------------------------------------------------------------- Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. -------------------------------------------------------------------------------- Company Information 23.04.2008 Erlangen, 23rd April 2008. With approval of the Supervisory Board november AG assigns its 51% share of PELAB Biotechnologie GmbH with immediate effect. The compensation of EUR 1,500,000.00 will be payable by instalments. end of announcement euro adhoc -------------------------------------------------------------------------------- ots Originaltext: november AG Im Internet recherchierbar: http://www.presseportal.ch Further inquiry note: Marcus Weichert Leitung PR/IR Telefon: +49(0)9131 75088 868 E-Mail: weichert@november.de Branche: Biotechnology ISIN: DE000A0S9N72 WKN: A0S9N7 Index: CDAX, Prime All Share, Technologie All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Stuttgart / free trade Börse Düsseldorf / free trade Börse Hannover / free trade Börse München / free trade

Das könnte Sie auch interessieren: